Camp4 Therapeutics Corp - Common Stock (CAMP)

Historical Holders from Q4 2024 to Q3 2025

Type / Class
Equity / Common Stock
Symbol
CAMP on Nasdaq
Shares outstanding
51,701,934
Price per share
$3.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
28,210,083
Total reported value
$84,630,390
% of total 13F portfolios
0%
Share change
+16,466,303
Value change
+$49,505,803
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
28
Price from insider filings
$1.53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Camp4 Therapeutics Corp - Common Stock (CAMP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 12% $37,908,892 6,307,636 JANUS HENDERSON GROUP PLC 31 Dec 2025
5AM Ventures VI, L.P. 12% $11,855,564 5,869,091 Andrew J. Schwab 09 Sep 2025
Coastlands Capital LP 10% $21,452,710 4,886,722 Coastlands Capital LP 10 Sep 2025
Polaris Management Co. VII, L.L.C. 8.4% $7,943,147 3,932,251 Amir Nashat 09 Sep 2025
Vivo Opportunity Fund Holdings, L.P. 7.6% $7,194,822 3,561,793 Vivo Opportunity Fund Holdings, L.P. 11 Sep 2025
FMR LLC 6.7% -55% $9,657,185 +$375,243 3,145,663 +4% FMR LLC 31 Oct 2025
Enavate Sciences GP, LLC 6% -26% $13,729,110 -$2,890,560 3,127,360 -17% Enavate Sciences GP, LLC 19 Dec 2025
Northpond Ventures II, LP 4.8% $6,871,409 2,238,244 Michael P. Rubin 30 Sep 2025
AH Bio Fund I, L.P. 4.5% $6,524,791 2,125,339 Marc L. Andreessen 30 Sep 2025
HARBOURVEST PARTNERS LLC 2.7% -60% $3,536,015 1,271,948 0% HarbourVest Partners L.P. 30 Sep 2025
As of 30 Sep 2025, Camp4 Therapeutics Corp - Common Stock (CAMP) has 28 institutional shareholders filing 13F forms. They hold 28,210,083 shares of 51,701,934 outstanding shares (55%) .

Top 25 institutional shareholders own 55% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
5AM Venture Management, LLC 11% 5,869,091 +100% 6.4% $17,607,273
JANUS HENDERSON GROUP PLC 9% 4,640,970 0.01% $13,922,910
Vivo Capital, LLC 7.6% 3,921,568 0.95% $11,764,704
ENAVATE SCIENCES GP, LLC 7.3% 3,785,802 0% 3.5% $11,357,406
FMR LLC 5.8% 3,023,434 +397% 0% $9,070,302
a16z Capital Management, L.L.C. 4.1% 2,125,339 0% 0.46% $6,376,017
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.8% 1,960,784 0.01% $5,882,352
HarbourVest Partners LLC 2.5% 1,271,948 0% 1.9% $3,815,844
SILVERARC CAPITAL MANAGEMENT, LLC 1.3% 653,594 0.28% $1,960,782
VANGUARD GROUP INC 0.61% 313,506 -4.7% 0% $940,518
Alyeska Investment Group, L.P. 0.39% 200,000 0% 0% $600,000
TWO SIGMA INVESTMENTS, LP 0.19% 97,371 0% $292,113
MILLENNIUM MANAGEMENT LLC 0.18% 95,071 -29% 0% $285,213
VICTORY CAPITAL MANAGEMENT INC 0.16% 82,790 -0.33% 0% $248,370
GEODE CAPITAL MANAGEMENT, LLC 0.12% 60,371 -20% 0% $181,113
STATE STREET CORP 0.05% 26,000 0% $78,000
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.05% 25,000 0% 0% $75,000
Mariner, LLC 0.03% 17,298 0% $51,894
NORTHERN TRUST CORP 0.03% 14,615 0% 0% $43,845
BlackRock, Inc. 0.02% 11,437 -86% 0% $34,311
UBS Group AG 0.01% 7,043 +38% 0% $21,129
Tower Research Capital LLC (TRC) 0.01% 5,649 +47% 0% $16,947
ROYAL BANK OF CANADA 0% 953 +80% 0% $3,000
BANK OF AMERICA CORP /DE/ 0% 283 -57% 0% $849
BNP PARIBAS FINANCIAL MARKETS 0% 78 0% 0% $234

Institutional Holders of Camp4 Therapeutics Corp - Common Stock (CAMP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 28,210,083 $84,630,390 +$49,505,803 $3.00 28
2025 Q2 11,744,129 $17,029,220 -$3,217,596 $1.45 28
2025 Q1 12,677,488 $50,709,955 -$1,002,765 $4.00 39
2024 Q4 12,854,057 $67,096,861 +$47,332,166 $5.22 36